9.3f How can the health sector work more effectively with other sectors to deliver more effective public health services to tackle infectious disease burdens, i.e. through One Health approaches?

Background

FCDO supports long-term research investment to tackle a range of global health problems. This spans areas such as preventable maternal and childhood mortality, comprehensive sexual and reproductive health and rights (SRHR), diseases of poverty (such as malaria, TB, HIV/AIDS and Neglected Tropical Diseases) emerging infectious diseases and diseases of epidemic potential.
We support the development of and equitable access to new vaccines, diagnostics and treatments; applied research to strengthen health systems and financing, and building inclusive and equitable partnerships for collaborative research. We recognise the scientific strengths of partner countries and the importance of localised, context specific research. Greater evidence and research are needed on how increased conflict and fragility, climate change and food insecurity are challenging efforts to make progress towards the health SDGs, especially for the most vulnerable people in LMICs.

Next steps

Get in touch with [email protected]

Related UKRI funded projects

  • MRC Centre for Global Infectious Disease Analysis (MRC GIDA)

    The COVID-19 pandemic has clearly illustrated the potential impact that emerging infectious diseases can have on health and on society. Being better prepared for future threats is therefore a key priority for public heal...

    Funded by: MRC

    Lead research organisation: Imperial College London

    Why might this be relevant?

    The project focuses on global infectious diseases, including HIV, tuberculosis, and malaria, and how to best deploy new tools for public health control.

  • E Ochodo, Stellenbosch University, Evidence synthesis for building a translation pipeline to eliminate infectious diseases

    Infectious diseases such as HIV, tuberculosis (TB) and malaria still cause considerable illness and death in Africa. This is despite malaria and TB being treatable, the availability of tests to detect these diseases and ...

    Funded by: MRC

    Lead research organisation: Liverpool School of Tropical Medicine

    Why might this be relevant?

    The project aims to summarize research findings on HIV, TB, and malaria to inform policy, but does not directly address One Health approaches.

  • MRC Centre for Global Infectious Disease Analysis

    The continuing threat from new infectious diseases has been highlighted in recent years by the emergence of MERS-coronavirus in the Middle East, Ebola in West Africa and Zika in Latin America. Preparing for and respondin...

    Funded by: MRC

    Lead research organisation: Imperial College London

    Why might this be relevant?

    The project focuses on infectious disease modelling and analysis, but does not specifically address collaboration with other sectors for One Health approaches.

  • Understanding non-communicable diseases (NCD) and the role of infection in Africa: building a partnership to generate big data

    "Non-communicable diseases" (NCD) are increasing in Africa. They are a diverse group of conditions, not directly caused by infections and are most often long-term and lifestyle-related, such as diabetes, high b...

    Funded by: MRC

    Lead research organisation: London School of Hygiene and Tropical Medicine

  • CONTAGIO

    CONTAGIO is a consortium of investigators from Europe, North America, Latin America, Asia, and Africa, that aims to create coordination mechanisms to rapidly react to infectious disease (re-)emergence in low- and middle-...

    Funded by: Horizon Europe Guarantee

    Lead research organisation: LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE

  • Innovative spending: what should money be spent on to make global health innovations more effective in developing countries?

    Health care in developing countries, certainly, but also even in developed countries-is ailing and in need of strengthening. While it is true that medical treatment has made astonishing advances over the years, the packa...

    Funded by: ESRC

    Lead research organisation: The Open University

  • Mobilising Scotland's Assets in equitable ways for Epidemic Control (MOSAEC)

    Context and rationale: Stakeholder engagement has led the Phase 1 team to focus here on a pathogen agnostic approach mobilising existing epidemic assets (i.e., assets such as diverse organisations, communities, technolog...

    Funded by: MRC

    Lead research organisation: University of Strathclyde

  • Southern Africa Research Capacity Network (SOFAR)

    The SOuthern aFrica Research cApacity netwoRk (SOFAR) will train a generation of innovative world class and resilient African scientists, clinicians and public health professionals facilitated by a partnership of two hig...

    Funded by: Horizon Europe Guarantee

    Lead research organisation: LONDON SCH OF HYGIENE & TROPIC. MEDICINE

  • The DOMINO Study: Measuring and mitigating the indirect effects of COVID-19 on TB and HIV care in Indonesia

    The disruption to TB and HIV health services brought about by the COVID-19 pandemic, if sustained over six-months, has been predicted to result in 1.4 million extra deaths from TB-related illnesses and over 500,000 from ...

    Funded by: COVID

    Lead research organisation: London School of Hygiene and Tropical Medicine

  • GCRF_NF391 Maximising benefit and minimising the harm of COVID-19 control measures on child and women's health in four Sub-Saharan African countries

    COVID-19 is challenging everywhere because many of the measures to control the disease also produce negative effects. This is especially the case in Sub-Saharan Africa (SSA) where health systems are relatively under-reso...

    Funded by: GCRF

    Lead research organisation: Queen Mary University of London